Overview

Effect of Platelet Inhibition and / or Lipid Lowering in Non-ACS-patients With Positive Troponin

Status:
Recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The study evaluates the effect of platelet inhibition and / or lipid lowering in non-ACS-patients with symptoms suggestive for ACS, and elevated high-sensitivity troponin values
Phase:
Phase 3
Details
Lead Sponsor:
Dr. med. Mahir Karakas
Universitätsklinikum Hamburg-Eppendorf
Treatments:
Aspirin
Atorvastatin
Atorvastatin Calcium